This is the authors' abstract. We don't add key points for this paper.
Background Patients with major depressive disorder (MDD) usually manifest sleep disturbance. Early morning awakening is more closely related to MDD than other sleep disturbances. Aim The aim of this study was to assess the effect of early morning awakening in the treatment of patients with MDD. Methods Eligible patients were randomly assigned into two groups: early morning awakening and non-early morning awakening group. All patients were assessed using Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), and Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) scores at baseline and the fourth week. Results Twenty-one men and 31 women (mean age 25.13 ±10.67 years) were enrolled. There is a significant main effect of early morning awakening in HAMD (P =0.04) and HAMA (P =0.01) at fourth week after escitalopram treatment. Discussion This trial suggests that early morning awakening may result in statistically and clinically significant delay in the recovery of the MDD but cognitive impairment.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2022) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: